Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention
Keywords: استفاده جهانی از استراتژی برای باز کردن عروق کرونر; antiplatelet therapy; bleeding; coronary artery disease; outcomes; CHAMPION; Cangrelor versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition; CI; confidence interval; GPI; glycoprotein IIb/IIIa inhibitor; GUSTO; Global Use of Strate